Two Million Ohioans Stand to Benefit From New Drug Price Provisions From Inflation Reduction Act



 

Medicare will Have Power to Negotiate Lower Drug Costs for Seniors, & Insulin Savings Begin Next Year, in “Rare Defeat for Big Pharma”

WASHINGTON, DC – U.S. Senator Sherrod Brown (D-OH), long a leader in efforts to lower prescription drug prices, is alerting Ohio seniors to benefits the groundbreaking Inflation Reduction Act of 2022, which will save Ohioans on Medicare at the pharmacy counter, in what one news organization called “a rare defeat for Big Pharma.” Nearly 2 million Ohio seniors are enrolled in Medicare part D coverage and will benefit from new law to reduce drug price inflation.

“We know Ohioans are struggling with high prices right now, and prescription drugs are some of the most overpriced goods many families are forced to pay for each month. After years of fighting opposition from Big Pharma, and the politicians who always do their lobbyists’ bidding, we are finally making progress to bring down drug prices for seniors,” said Brown. “The Inflation Reduction Act finally takes on the drug companies to lower drug prices, particularly for Americans on Medicare.”

For years, Brown has led efforts to allow Medicare to negotiate directly with pharmaceutical companies and to lower drug prices for all Americans. Now the Inflation Reduction Act will:

One thought on “Two Million Ohioans Stand to Benefit From New Drug Price Provisions From Inflation Reduction Act

  1. Thanks to Senator Brown and the Democrats for fighting for Seniors and the Middle class. To continue the success of the Democrats we must elect Ryan to replace Portman who is retiring this year!!

Comments are closed.